N1-Methyl-lysergic acid diethylamide
Systematic (IUPAC) name | |
---|---|
(8β)-N,N-Diethyl-1,6-dimethyl-9,10-didehydroergoline-8-carboxamide | |
Clinical data | |
Routes of administration | Oral |
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
CAS Number | 4238-85-1 |
PubChem | CID 165200 |
ChemSpider | 144824 |
Synonyms | MLD-41, N1- Methyl- Lysergic Acid Diethylamide |
Chemical data | |
Formula | C21H27N3O |
Molar mass | 337.47 g/mol |
| |
| |
(verify) |
N1-Methyl-lysergic acid diethylamide (MLD-41) is a derivative of LSD.
Metabolism of other 1-methylated-ergoloids to their secondary amine derivatives has been frequently noted in mammals.[1]
References
- ↑ Müller-Schweinitzer and Tapparelli (1986). Methylergometrine, an active metabolite of methysergide. Cephalalgia. 6: 35-41.
This article is issued from Wikipedia - version of the Friday, September 18, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.